Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death | MicrobiomeTrials← Back to trialsNCT00246857
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 5,000 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Ankara Medical University, Ankara, Turkey (Türkiye)
- Gazi University, Ankara, Turkey (Türkiye)
- Hacettepe University, Ankara, Turkey (Türkiye)
- Marmara University, Istanbul, Turkey (Türkiye)
- Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey (Türkiye)
- Necemttin Erbakan University, Konya, Turkey (Türkiye)
Other microbiome trials you might be interested in
DOCK8 Deficiency
Background:
-DOCK8 deficiency is a genetic disorder that affects the immune system and can lead to severe recurrent inf…
Bethesda, United StatesEst. completion Oct 31, 2026
HIV
There is evidence that early and aggressive treatment with antiretroviral drugs can prevent the loss of immune cell func…
Bethesda, United States
Chronic Graft vs. Host Disease
Background:
* Chronic graft-versus-host disease (cGVHD) is a multi-organ alloimmune and autoimmune disorder that occurs…